Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

That unexplained morning bloating or stomach discomfort might have less to do with what you ate and more with how you slept.

"This is because this position keeps the stomach contents below the level of the gastro-esophageal junction." Tau also cautions: "Do not try and cope with abdominal pain alone. Always contact your ...

Less than one-quarter of oncologists surveyed indicated that every one of their patients with advanced gastric or gastroesophageal junction cancers received biomarker testing consistent with practice ...

Stomach or gastric cancer forms when cancer cells grow out of control in your stomach. It happens when abnormal cell growth meets your esophagus or the gastroesophageal junction. Doctors say more ...

The Business Research Company's Gastroesophageal Junction Adenocarcinoma Therapeutics Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 2025 Market Reports Released ...

European certification for PD-L1 IHC 22C3 pharmDx to help gastric or GEJ adenocarcinoma patients for KEYTRUDA® therapy SANTA ...

GERD is short for gastroesophageal reflux disease. It is a chronic disease where the contents of the stomach, particularly acid, reflux into the esophagus. The acid, through various mechanisms, ...

Shares in US biotech Five Prime Therapeutics more than tripled after it reported promising trial results with stomach cancer ... advanced gastric and gastroesophageal junction cancer met all ...

esophageal cancer, head and neck squamous cell carcinoma (HNSCC), triple-negative breast cancer (TNBC), and cervical cancer patients for treatment with KEYTRUDA. Consequently, PD-L1 IHC 22C3 ...